The Lieber Institute for Brain Development (LIBD) employs a multifaceted approach to neuroscience research, focusing on understanding the complexities of brain development and its associated disorders. One of the key initiatives is the African Ancestry Neuroscience Research Initiative, which aims to address health disparities in neuroscience research by emphasizing the importance of diverse genetic backgrounds. The institute also maintains a unique Brain Repository, which houses over 4,000 brain samples, providing critical biological material for research. This resource is instrumental in advancing studies in functional genomics, molecular psychiatry, and developmental biology, ultimately contributing to a deeper understanding of various neurological conditions.

In addition to its repository, LIBD is actively engaged in drug discovery and development, utilizing human cell lines and data science to identify potential therapeutic targets. The institute's BrainSEQ™ Consortium focuses on sequencing brain genomes to uncover genetic factors linked to mental health disorders, while its translational clinical programs aim to bridge the gap between laboratory research and clinical application. By integrating advanced technologies in clinical pharmacology and molecular neuropathology, LIBD is committed to unlocking the mysteries of the brain and developing innovative treatments for mental health challenges.

United States

Lieber Institute for Brain Development is a research institute focused on advancing understanding of brain development and disorders.

Lieber Institute for Brain Development

Company Details